Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Esophageal Neoplasms | 10 | 2024 | 1648 | 1.860 |
Why?
|
Contractile Proteins | 2 | 2020 | 240 | 1.290 |
Why?
|
Hypertension, Portal | 2 | 2023 | 226 | 0.930 |
Why?
|
Intercellular Signaling Peptides and Proteins | 2 | 2020 | 1652 | 0.830 |
Why?
|
Gastritis, Atrophic | 1 | 2022 | 31 | 0.820 |
Why?
|
Papillomavirus Infections | 3 | 2024 | 1607 | 0.770 |
Why?
|
Carcinoma, Verrucous | 1 | 2021 | 27 | 0.760 |
Why?
|
Adenocarcinoma | 8 | 2023 | 6315 | 0.750 |
Why?
|
Immunohistochemistry | 10 | 2024 | 11071 | 0.730 |
Why?
|
Stomach Neoplasms | 5 | 2023 | 1423 | 0.720 |
Why?
|
Gastritis | 1 | 2022 | 198 | 0.700 |
Why?
|
Deoxyribonuclease I | 2 | 2014 | 224 | 0.700 |
Why?
|
Stromal Cells | 3 | 2022 | 1326 | 0.640 |
Why?
|
Gallbladder Neoplasms | 1 | 2020 | 190 | 0.640 |
Why?
|
Helicobacter pylori | 1 | 2022 | 377 | 0.630 |
Why?
|
Helicobacter Infections | 1 | 2022 | 386 | 0.630 |
Why?
|
Hepatic Duct, Common | 1 | 2017 | 48 | 0.590 |
Why?
|
Telomerase | 1 | 2021 | 746 | 0.520 |
Why?
|
beta Catenin | 1 | 2021 | 1043 | 0.520 |
Why?
|
Duodenal Diseases | 1 | 2015 | 99 | 0.500 |
Why?
|
Precancerous Conditions | 1 | 2022 | 977 | 0.500 |
Why?
|
Bile Duct Diseases | 1 | 2014 | 97 | 0.470 |
Why?
|
Gastrointestinal Stromal Tumors | 1 | 2020 | 615 | 0.470 |
Why?
|
Esophagectomy | 3 | 2023 | 466 | 0.460 |
Why?
|
Cholangiocarcinoma | 2 | 2021 | 550 | 0.460 |
Why?
|
DNA Cleavage | 1 | 2014 | 57 | 0.450 |
Why?
|
Tumor Suppressor Protein p53 | 1 | 2024 | 2919 | 0.440 |
Why?
|
Bile Ducts, Intrahepatic | 1 | 2014 | 296 | 0.440 |
Why?
|
Liver Cirrhosis | 4 | 2023 | 1931 | 0.430 |
Why?
|
GATA3 Transcription Factor | 1 | 2013 | 152 | 0.430 |
Why?
|
Cholangitis, Sclerosing | 1 | 2014 | 177 | 0.420 |
Why?
|
Glomerulonephritis | 1 | 2014 | 337 | 0.420 |
Why?
|
Antibodies, Antineutrophil Cytoplasmic | 1 | 2014 | 288 | 0.420 |
Why?
|
Kidney Glomerulus | 1 | 2014 | 568 | 0.410 |
Why?
|
Liver Neoplasms | 3 | 2023 | 4319 | 0.390 |
Why?
|
Chemotaxis | 1 | 2014 | 598 | 0.390 |
Why?
|
Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis | 1 | 2014 | 225 | 0.380 |
Why?
|
Inflammatory Bowel Diseases | 4 | 2023 | 2421 | 0.380 |
Why?
|
Adenomatous Polyps | 2 | 2024 | 108 | 0.370 |
Why?
|
Neoadjuvant Therapy | 4 | 2024 | 2821 | 0.320 |
Why?
|
Diarrhea | 1 | 2015 | 1319 | 0.320 |
Why?
|
DNA Restriction Enzymes | 1 | 2008 | 553 | 0.320 |
Why?
|
Amyloidosis | 1 | 2015 | 817 | 0.320 |
Why?
|
Models, Molecular | 4 | 2009 | 5434 | 0.310 |
Why?
|
Colitis | 2 | 2014 | 1229 | 0.310 |
Why?
|
Barrett Esophagus | 2 | 2023 | 490 | 0.300 |
Why?
|
Liver Failure, Acute | 2 | 2021 | 181 | 0.290 |
Why?
|
Colonic Neoplasms | 1 | 2019 | 2526 | 0.290 |
Why?
|
Binding Sites | 2 | 2014 | 6048 | 0.280 |
Why?
|
Weight Loss | 2 | 2015 | 2686 | 0.280 |
Why?
|
Carcinoma, Transitional Cell | 1 | 2013 | 800 | 0.280 |
Why?
|
Protein Folding | 2 | 2008 | 867 | 0.270 |
Why?
|
Carcinoma, Pancreatic Ductal | 2 | 2014 | 1724 | 0.270 |
Why?
|
Carcinoma, Squamous Cell | 1 | 2022 | 4024 | 0.270 |
Why?
|
Intestine, Small | 2 | 2024 | 1207 | 0.270 |
Why?
|
Fatty Liver | 2 | 2022 | 778 | 0.250 |
Why?
|
Hyperplasia | 3 | 2023 | 1155 | 0.240 |
Why?
|
Bacterial Proteins | 2 | 2008 | 3826 | 0.230 |
Why?
|
Observer Variation | 2 | 2021 | 2601 | 0.230 |
Why?
|
Pancreatic Neoplasms | 3 | 2020 | 5351 | 0.220 |
Why?
|
Esophagogastric Junction | 3 | 2023 | 341 | 0.220 |
Why?
|
Neoplasm Metastasis | 1 | 2013 | 4902 | 0.210 |
Why?
|
Histiocytosis, Langerhans-Cell | 1 | 2024 | 169 | 0.210 |
Why?
|
Aberrant Crypt Foci | 1 | 2022 | 12 | 0.200 |
Why?
|
Human papillomavirus 16 | 1 | 2024 | 265 | 0.200 |
Why?
|
Bile Acids and Salts | 1 | 2024 | 382 | 0.200 |
Why?
|
Fatty Liver, Alcoholic | 1 | 2022 | 36 | 0.200 |
Why?
|
Colorectal Neoplasms | 4 | 2024 | 6853 | 0.200 |
Why?
|
Granuloma, Foreign-Body | 1 | 2021 | 42 | 0.190 |
Why?
|
Humans | 49 | 2024 | 760621 | 0.190 |
Why?
|
Hepatitis | 1 | 2023 | 230 | 0.190 |
Why?
|
Metaplasia | 1 | 2022 | 320 | 0.190 |
Why?
|
Macrophages | 2 | 2022 | 5745 | 0.190 |
Why?
|
Doxycycline | 2 | 2013 | 341 | 0.190 |
Why?
|
Early Growth Response Transcription Factors | 1 | 2020 | 31 | 0.180 |
Why?
|
Urinary Bladder Neoplasms | 1 | 2013 | 2276 | 0.180 |
Why?
|
Aged | 19 | 2024 | 169152 | 0.180 |
Why?
|
North America | 1 | 2024 | 1284 | 0.180 |
Why?
|
Carcinoma, Hepatocellular | 2 | 2023 | 2299 | 0.180 |
Why?
|
Amiodarone | 1 | 2022 | 218 | 0.180 |
Why?
|
Middle Aged | 21 | 2024 | 220352 | 0.180 |
Why?
|
Keratins | 1 | 2021 | 497 | 0.180 |
Why?
|
Alkaline Phosphatase | 1 | 2023 | 865 | 0.180 |
Why?
|
Antineoplastic Agents | 1 | 2023 | 13630 | 0.170 |
Why?
|
Liver Diseases | 2 | 2022 | 1302 | 0.170 |
Why?
|
Gastric Mucosa | 2 | 2013 | 599 | 0.170 |
Why?
|
Peripheral Vascular Diseases | 2 | 2013 | 515 | 0.170 |
Why?
|
Liver | 5 | 2023 | 7509 | 0.170 |
Why?
|
Smooth Muscle Tumor | 1 | 2020 | 63 | 0.170 |
Why?
|
Male | 26 | 2024 | 359744 | 0.160 |
Why?
|
Female | 29 | 2024 | 391270 | 0.160 |
Why?
|
Adenocarcinoma, Mucinous | 1 | 2023 | 517 | 0.160 |
Why?
|
Goblet Cells | 1 | 2022 | 299 | 0.160 |
Why?
|
Kruppel-Like Transcription Factors | 1 | 2020 | 503 | 0.150 |
Why?
|
Receptor, erbB-2 | 2 | 2020 | 2554 | 0.150 |
Why?
|
DNA, Viral | 1 | 2024 | 2194 | 0.140 |
Why?
|
Protein Structure, Quaternary | 2 | 2008 | 428 | 0.140 |
Why?
|
Gastrectomy | 1 | 2021 | 679 | 0.140 |
Why?
|
Gastrointestinal Diseases | 1 | 2024 | 1190 | 0.130 |
Why?
|
Esophagitis | 2 | 2013 | 163 | 0.120 |
Why?
|
Lithiasis | 1 | 2014 | 19 | 0.120 |
Why?
|
Gene Rearrangement | 1 | 2020 | 1122 | 0.120 |
Why?
|
Anemia, Sickle Cell | 1 | 2023 | 1056 | 0.120 |
Why?
|
Diagnosis, Differential | 3 | 2023 | 12965 | 0.120 |
Why?
|
Biopsy | 3 | 2015 | 6771 | 0.120 |
Why?
|
Adult | 16 | 2024 | 219994 | 0.120 |
Why?
|
Cholangiography | 1 | 2014 | 181 | 0.120 |
Why?
|
Fructose | 1 | 2016 | 287 | 0.120 |
Why?
|
Capillaries | 2 | 2014 | 744 | 0.120 |
Why?
|
Bariatric Surgery | 1 | 2024 | 1005 | 0.120 |
Why?
|
Panax notoginseng | 1 | 2013 | 3 | 0.120 |
Why?
|
Spectrometry, Mass, Matrix-Assisted Laser Desorption-Ionization | 1 | 2015 | 508 | 0.110 |
Why?
|
Antigens, Differentiation, Myelomonocytic | 1 | 2014 | 282 | 0.110 |
Why?
|
Necrosis | 2 | 2014 | 1612 | 0.110 |
Why?
|
Cholelithiasis | 1 | 2014 | 408 | 0.110 |
Why?
|
Gene Amplification | 2 | 2015 | 1085 | 0.110 |
Why?
|
Dilatation, Pathologic | 1 | 2014 | 527 | 0.110 |
Why?
|
Down-Regulation | 1 | 2020 | 2913 | 0.110 |
Why?
|
Splenectomy | 1 | 2014 | 391 | 0.110 |
Why?
|
Stomach Diseases | 1 | 2014 | 133 | 0.110 |
Why?
|
Microscopy, Electron, Transmission | 1 | 2014 | 697 | 0.110 |
Why?
|
Aged, 80 and over | 8 | 2021 | 58995 | 0.100 |
Why?
|
Duodenum | 1 | 2015 | 486 | 0.100 |
Why?
|
Calcinosis | 1 | 2021 | 1476 | 0.100 |
Why?
|
Neutrophil Infiltration | 1 | 2014 | 393 | 0.100 |
Why?
|
Gastrointestinal Neoplasms | 1 | 2020 | 951 | 0.100 |
Why?
|
Tissue Array Analysis | 1 | 2013 | 551 | 0.100 |
Why?
|
Interleukin-6 | 1 | 2022 | 3215 | 0.100 |
Why?
|
Macrophage Activation | 1 | 2014 | 554 | 0.100 |
Why?
|
High-Throughput Nucleotide Sequencing | 1 | 2024 | 3616 | 0.100 |
Why?
|
Spectrometry, Fluorescence | 1 | 2014 | 687 | 0.100 |
Why?
|
Carcinoma | 1 | 2023 | 2331 | 0.100 |
Why?
|
Nausea | 1 | 2014 | 678 | 0.090 |
Why?
|
Neoplasm Invasiveness | 1 | 2019 | 3618 | 0.090 |
Why?
|
Vomiting | 1 | 2014 | 650 | 0.090 |
Why?
|
Homeodomain Proteins | 1 | 2020 | 2414 | 0.090 |
Why?
|
Endoscopy, Gastrointestinal | 2 | 2014 | 867 | 0.090 |
Why?
|
Intestinal Mucosa | 1 | 2022 | 3022 | 0.090 |
Why?
|
Proto-Oncogene Proteins c-met | 1 | 2014 | 567 | 0.090 |
Why?
|
Obesity | 2 | 2024 | 12922 | 0.090 |
Why?
|
Transcription, Genetic | 1 | 2024 | 7593 | 0.090 |
Why?
|
RNA, Messenger | 2 | 2022 | 12766 | 0.090 |
Why?
|
Pancreatectomy | 1 | 2014 | 810 | 0.090 |
Why?
|
Plant Extracts | 1 | 2013 | 496 | 0.090 |
Why?
|
Specimen Handling | 1 | 2014 | 707 | 0.090 |
Why?
|
Promoter Regions, Genetic | 1 | 2021 | 5785 | 0.080 |
Why?
|
Treatment Outcome | 7 | 2024 | 65017 | 0.080 |
Why?
|
Flucytosine | 1 | 2009 | 33 | 0.080 |
Why?
|
Substrate Specificity | 1 | 2014 | 1792 | 0.080 |
Why?
|
In Situ Hybridization, Fluorescence | 1 | 2015 | 2506 | 0.080 |
Why?
|
Cytosine Deaminase | 1 | 2009 | 65 | 0.080 |
Why?
|
Synechocystis | 1 | 2008 | 9 | 0.080 |
Why?
|
Bile Duct Neoplasms | 1 | 2014 | 602 | 0.080 |
Why?
|
Epithelial Cells | 1 | 2021 | 3663 | 0.080 |
Why?
|
Creatinine | 1 | 2014 | 1903 | 0.080 |
Why?
|
Sarcoidosis | 1 | 2014 | 520 | 0.080 |
Why?
|
Mice, Inbred C57BL | 2 | 2024 | 22023 | 0.080 |
Why?
|
Causality | 1 | 2014 | 1242 | 0.080 |
Why?
|
Protein Structure, Secondary | 2 | 2008 | 1229 | 0.080 |
Why?
|
Immunity, Innate | 1 | 2020 | 3047 | 0.080 |
Why?
|
Nucleic Acid Conformation | 2 | 2008 | 899 | 0.080 |
Why?
|
High-Throughput Screening Assays | 1 | 2014 | 944 | 0.070 |
Why?
|
Sepsis | 1 | 2021 | 2592 | 0.070 |
Why?
|
Mass Spectrometry | 1 | 2014 | 2192 | 0.070 |
Why?
|
T-Lymphocytes, Regulatory | 1 | 2020 | 3075 | 0.070 |
Why?
|
Insulin Resistance | 1 | 2020 | 3959 | 0.070 |
Why?
|
Anticonvulsants | 1 | 2016 | 1879 | 0.070 |
Why?
|
Endodeoxyribonucleases | 1 | 2007 | 164 | 0.070 |
Why?
|
Pancreatitis | 1 | 2013 | 1100 | 0.070 |
Why?
|
Antibodies, Monoclonal | 1 | 2023 | 9185 | 0.070 |
Why?
|
Amino Acid Sequence | 2 | 2008 | 13451 | 0.070 |
Why?
|
Mutation | 3 | 2024 | 29932 | 0.070 |
Why?
|
Thermodynamics | 1 | 2007 | 599 | 0.070 |
Why?
|
Reproducibility of Results | 2 | 2023 | 20080 | 0.070 |
Why?
|
Young Adult | 4 | 2024 | 58741 | 0.060 |
Why?
|
Child | 5 | 2024 | 79806 | 0.060 |
Why?
|
Receptors, Cell Surface | 1 | 2014 | 2825 | 0.060 |
Why?
|
Molecular Sequence Data | 2 | 2008 | 17624 | 0.060 |
Why?
|
Databases, Factual | 1 | 2020 | 8035 | 0.060 |
Why?
|
Lithocholic Acid | 1 | 2024 | 24 | 0.060 |
Why?
|
Amino Acid Motifs | 1 | 2007 | 929 | 0.060 |
Why?
|
Anti-Bacterial Agents | 2 | 2013 | 7408 | 0.060 |
Why?
|
Apolipoprotein A-I | 1 | 2005 | 297 | 0.060 |
Why?
|
Introns | 1 | 2007 | 978 | 0.060 |
Why?
|
Antigens, CD | 1 | 2014 | 4000 | 0.060 |
Why?
|
Disease Progression | 2 | 2020 | 13502 | 0.060 |
Why?
|
Adolescent | 4 | 2024 | 87810 | 0.060 |
Why?
|
Predictive Value of Tests | 1 | 2020 | 15289 | 0.060 |
Why?
|
Sensitivity and Specificity | 2 | 2023 | 14660 | 0.060 |
Why?
|
Glutamate-Ammonia Ligase | 1 | 2023 | 72 | 0.060 |
Why?
|
DNA, Bacterial | 1 | 2008 | 1456 | 0.060 |
Why?
|
Neoplasm Recurrence, Local | 1 | 2021 | 9276 | 0.050 |
Why?
|
Case-Control Studies | 1 | 2020 | 22053 | 0.050 |
Why?
|
Sodium Azide | 1 | 2002 | 24 | 0.050 |
Why?
|
Recurrence | 1 | 2014 | 8482 | 0.050 |
Why?
|
Mutagenesis, Site-Directed | 1 | 2005 | 1693 | 0.050 |
Why?
|
Crystallography, X-Ray | 1 | 2007 | 1982 | 0.050 |
Why?
|
United States | 3 | 2024 | 72461 | 0.050 |
Why?
|
Escherichia coli Proteins | 1 | 2009 | 1066 | 0.050 |
Why?
|
Proteomics | 1 | 2015 | 3817 | 0.050 |
Why?
|
Autoimmune Diseases | 1 | 2013 | 2250 | 0.050 |
Why?
|
Longitudinal Studies | 1 | 2017 | 14495 | 0.050 |
Why?
|
Transforming Growth Factor beta3 | 1 | 2020 | 44 | 0.050 |
Why?
|
Thioredoxins | 1 | 2002 | 201 | 0.050 |
Why?
|
Apoptosis | 2 | 2023 | 9501 | 0.040 |
Why?
|
Diabetes Mellitus, Type 2 | 1 | 2024 | 12293 | 0.040 |
Why?
|
Phosphatidylinositol 3-Kinase | 1 | 2020 | 126 | 0.040 |
Why?
|
Comorbidity | 1 | 2014 | 10551 | 0.040 |
Why?
|
Gadolinium DTPA | 1 | 2023 | 823 | 0.040 |
Why?
|
von Willebrand Factor | 1 | 2023 | 673 | 0.040 |
Why?
|
Retrospective Studies | 6 | 2023 | 80372 | 0.040 |
Why?
|
Protein Binding | 2 | 2008 | 9335 | 0.040 |
Why?
|
Colonic Polyps | 1 | 2024 | 551 | 0.040 |
Why?
|
Alphapapillomavirus | 1 | 2020 | 218 | 0.040 |
Why?
|
DNA Helicases | 1 | 2023 | 854 | 0.040 |
Why?
|
Child, Preschool | 2 | 2024 | 42063 | 0.040 |
Why?
|
Phenotype | 1 | 2014 | 16546 | 0.030 |
Why?
|
Magnetic Resonance Imaging | 2 | 2023 | 36290 | 0.030 |
Why?
|
Cross-Sectional Studies | 1 | 2017 | 25942 | 0.030 |
Why?
|
Fibrosis | 1 | 2023 | 2042 | 0.030 |
Why?
|
Colonoscopy | 1 | 2024 | 1387 | 0.030 |
Why?
|
Base Sequence | 1 | 2007 | 12446 | 0.030 |
Why?
|
Ligands | 1 | 2023 | 3276 | 0.030 |
Why?
|
Neoplasm, Residual | 1 | 2021 | 1007 | 0.030 |
Why?
|
Hyperammonemia | 1 | 2016 | 77 | 0.030 |
Why?
|
Mentors | 1 | 2021 | 661 | 0.030 |
Why?
|
Protein Engineering | 2 | 2009 | 541 | 0.030 |
Why?
|
Gastrointestinal Tract | 1 | 2021 | 830 | 0.030 |
Why?
|
Phagocytosis | 1 | 2020 | 1535 | 0.030 |
Why?
|
Lymphocytes, Tumor-Infiltrating | 1 | 2020 | 1088 | 0.030 |
Why?
|
Azoxymethane | 1 | 2013 | 35 | 0.030 |
Why?
|
Saponins | 1 | 2013 | 50 | 0.030 |
Why?
|
DNA | 1 | 2007 | 7233 | 0.030 |
Why?
|
Cell Differentiation | 2 | 2022 | 11481 | 0.030 |
Why?
|
Mice | 6 | 2024 | 81208 | 0.030 |
Why?
|
Computer Simulation | 1 | 2007 | 6218 | 0.030 |
Why?
|
Blood Coagulation Disorders | 1 | 2016 | 349 | 0.030 |
Why?
|
Chemotherapy, Adjuvant | 1 | 2021 | 3529 | 0.030 |
Why?
|
Lymphatic Metastasis | 1 | 2021 | 2943 | 0.030 |
Why?
|
Dextran Sulfate | 1 | 2013 | 255 | 0.030 |
Why?
|
Smad4 Protein | 1 | 2013 | 191 | 0.030 |
Why?
|
Immunoenzyme Techniques | 1 | 2015 | 1705 | 0.030 |
Why?
|
Monocytes | 1 | 2022 | 2575 | 0.030 |
Why?
|
Glucose | 1 | 2024 | 4351 | 0.030 |
Why?
|
Nitric Oxide Synthase Type II | 1 | 2013 | 514 | 0.020 |
Why?
|
RNA | 1 | 2022 | 2722 | 0.020 |
Why?
|
Cerebral Palsy | 1 | 2016 | 471 | 0.020 |
Why?
|
Combined Modality Therapy | 2 | 2016 | 8552 | 0.020 |
Why?
|
Enzyme Inhibitors | 1 | 2002 | 3726 | 0.020 |
Why?
|
Cyclooxygenase 2 | 1 | 2013 | 599 | 0.020 |
Why?
|
Risk Factors | 3 | 2024 | 74359 | 0.020 |
Why?
|
Endoscopy, Digestive System | 1 | 2013 | 351 | 0.020 |
Why?
|
Drug Monitoring | 1 | 2016 | 965 | 0.020 |
Why?
|
Kaplan-Meier Estimate | 1 | 2021 | 6544 | 0.020 |
Why?
|
DNA-Binding Proteins | 1 | 2007 | 9585 | 0.020 |
Why?
|
Contrast Media | 1 | 2023 | 5305 | 0.020 |
Why?
|
Prednisone | 1 | 2014 | 1565 | 0.020 |
Why?
|
Adipose Tissue | 1 | 2020 | 3301 | 0.020 |
Why?
|
Withholding Treatment | 1 | 2013 | 613 | 0.020 |
Why?
|
Animals | 6 | 2024 | 167963 | 0.020 |
Why?
|
Cells, Cultured | 2 | 2020 | 18957 | 0.020 |
Why?
|
ras Proteins | 1 | 2013 | 1052 | 0.020 |
Why?
|
HCT116 Cells | 1 | 2009 | 402 | 0.020 |
Why?
|
Nuclear Proteins | 1 | 2023 | 5791 | 0.020 |
Why?
|
Base Pair Mismatch | 1 | 2007 | 92 | 0.020 |
Why?
|
Calorimetry | 1 | 2007 | 129 | 0.020 |
Why?
|
Mitochondria | 1 | 2020 | 3600 | 0.020 |
Why?
|
Signal Transduction | 2 | 2020 | 23376 | 0.020 |
Why?
|
Mutant Proteins | 1 | 2009 | 492 | 0.020 |
Why?
|
Tumor Microenvironment | 1 | 2020 | 3844 | 0.020 |
Why?
|
Prodrugs | 1 | 2009 | 259 | 0.020 |
Why?
|
Positron-Emission Tomography | 1 | 2023 | 6465 | 0.020 |
Why?
|
Remission Induction | 1 | 2013 | 2392 | 0.020 |
Why?
|
Survival Rate | 1 | 2021 | 12808 | 0.020 |
Why?
|
Abdominal Pain | 1 | 2013 | 1063 | 0.020 |
Why?
|
Proportional Hazards Models | 1 | 2021 | 12531 | 0.020 |
Why?
|
Dimerization | 1 | 2007 | 891 | 0.020 |
Why?
|
Proto-Oncogene Proteins p21(ras) | 1 | 2013 | 1728 | 0.020 |
Why?
|
Colon | 1 | 2013 | 1788 | 0.020 |
Why?
|
Mice, Knockout | 1 | 2020 | 14372 | 0.020 |
Why?
|
Antimetabolites, Antineoplastic | 1 | 2009 | 640 | 0.020 |
Why?
|
DNA Mutational Analysis | 1 | 2013 | 4107 | 0.020 |
Why?
|
Glucocorticoids | 1 | 2014 | 2145 | 0.020 |
Why?
|
Cell Proliferation | 1 | 2020 | 10446 | 0.010 |
Why?
|
Protein Kinase Inhibitors | 1 | 2020 | 5643 | 0.010 |
Why?
|
Gene Expression Regulation, Neoplastic | 1 | 2020 | 8515 | 0.010 |
Why?
|
DNA Transposable Elements | 1 | 2007 | 756 | 0.010 |
Why?
|
Cell Line, Tumor | 1 | 2020 | 16939 | 0.010 |
Why?
|
Transcription Factors | 1 | 2023 | 12103 | 0.010 |
Why?
|
Nuclear Magnetic Resonance, Biomolecular | 1 | 2005 | 511 | 0.010 |
Why?
|
Mice, Nude | 1 | 2009 | 3607 | 0.010 |
Why?
|
Gene Expression Regulation | 1 | 2020 | 11903 | 0.010 |
Why?
|
Neurons | 1 | 2002 | 9426 | 0.010 |
Why?
|
Infant | 1 | 2024 | 36060 | 0.010 |
Why?
|
Immunoglobulin G | 1 | 2013 | 4541 | 0.010 |
Why?
|
Tumor Cells, Cultured | 1 | 2009 | 6131 | 0.010 |
Why?
|
Proto-Oncogene Proteins | 1 | 2013 | 4490 | 0.010 |
Why?
|
Inflammation | 1 | 2020 | 10756 | 0.010 |
Why?
|
Epilepsy | 1 | 2016 | 3267 | 0.010 |
Why?
|
Xenograft Model Antitumor Assays | 1 | 2009 | 3584 | 0.010 |
Why?
|
Protein Structure, Tertiary | 1 | 2007 | 3800 | 0.010 |
Why?
|
Mice, Inbred BALB C | 1 | 2009 | 6216 | 0.010 |
Why?
|
Neoplasms | 1 | 2009 | 22072 | 0.010 |
Why?
|
Risk Assessment | 1 | 2021 | 24123 | 0.010 |
Why?
|
Time Factors | 1 | 2021 | 40165 | 0.010 |
Why?
|
Prognosis | 1 | 2020 | 29658 | 0.010 |
Why?
|
Genetic Predisposition to Disease | 1 | 2020 | 17790 | 0.010 |
Why?
|
Postoperative Complications | 1 | 2021 | 15697 | 0.010 |
Why?
|
Lipid Metabolism | 1 | 2005 | 1902 | 0.010 |
Why?
|
Disease Models, Animal | 1 | 2013 | 18137 | 0.010 |
Why?
|
Rats | 1 | 2009 | 23711 | 0.010 |
Why?
|
Polymerase Chain Reaction | 1 | 2002 | 6068 | 0.010 |
Why?
|
Tomography, X-Ray Computed | 1 | 2014 | 20509 | 0.010 |
Why?
|